4//SEC Filing
McCracken Joseph S 4
Accession 0001126234-22-000092
CIK 0001126234other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:59 PM ET
Size
5.6 KB
Accession
0001126234-22-000092
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
McCracken Joseph S
Director
Transactions
- Purchase
Common Stock
2022-08-25$8.60/sh+3,170$27,262→ 11,721 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.52 to $8.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.
- [F2]Includes 237 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001632454
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:59 PM ET
- Size
- 5.6 KB